Medicines and Insurance Coverage (MedIC) Initiative Research

The Medicines and Insurance Coverage (MedIC) Initiative is a unique partnership between academics, health care delivery systems, health care financing institutions, and international organizations.  We seek to improve population health through evidence-informed medicines policies and programs in health systems, with a particular focus on emerging and expanding insurance schemes in low and middle-income countries (LMIC) working toward universal health coverage.
MedIC activities focus on
  • Capacity strengthening for medicines policy and program development in LMIC systems
  • Collaborative applied policy research on medicines management, programs, and policies in health care delivery and financing systems
  • Advancing methods for monitoring and evaluating impacts of medicines management, programs, and policies
  • Networking and sharing knowledge, experiences, and tools for evidence-informed decision making
The MedIC research portfolio addresses medicines access, affordability (from household and systems perspectives), and use of medicines in health systems and desired and potential undesired impacts of system changes on these outcomes. DPRG faculty conducting MedIC research include Drs. Christine Lu, Dennis Ross-Degnan, Anita Wagner, Catherine Vialle-Valentin, and Fang Zhang.  Pharmaceutical Policy Research Fellows frequently lead MedIC research projects.
Related Links
Principal Investigator: Anita Katharina Wagner
Funder(s): Funders of MedIC research projects include the China Medical Board; the Harvard Pilgrim Health Care Institute; Health Action International; the Harvard Medical School Fellowship in Pharmaceutical Policy Research; the IMS Institute for Health Care Informatics; the National University of Singapore Yong Loo Lin School of Medicine; the World Health Organization.
Related Resources